The main common feature of cancer cells is their ability to escape to homeostatic regulation mechanisms of living. In a sense giving them immortality, causing in the absence of treatment the death of the organism, which is their origin. The exponential knowledge of the biology of cancer and the phenomenal capacity of synthesis of new treatments and diagnostic tools have opened up the prospect of a precision medicine in oncology that requires regular and frequent updating of our knowledge.
This knowledge concerns both the intrinsic prognosis of the disease, as the prediction value of therapeutic approaches that in fact becomes increasingly “personalized”. This conference, organized for several years, aims to take stock of current and future tools that help us optimize the care of patients with cancer.
LEARNING OBJECTIVES
• Update the knowledge of the implications for practice and clinical research (tools to be used, tools still in research, areas where no tools are yet available)
• Understanding epigenetics and genomics research and their impact on cancer prognosis and therapy response (prediction)
MAIN TOPICS
• Epigenetics
• Pharmacogenomics/pharmacogenetics
• Immunology
• Lung cancer
• Colorectal cancer
• Prostate cancer
• Breast cancer
CME ACCREDITATION AND CERTIFICATES
Participants will be entitled to receive a certificate of attendance at the close of the Masterclass by completing the online evaluation questionnaire.
The event has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS). The evaluation of the event has been performed by the Accreditation Council of Oncology in Europe (ACOE) that acknowledged the quality of the scientific programme and its educational value. The event is designated for a maximum of 9 European CME credits (ECMEC).
Through an agreement between UEMS and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™.
Application for the Italian CME accreditation has been submitted and information on the status of the application can be obtained from the organising secretariat.
Molecular Diagnostics, Genomics and Epigenetics in Clinical Oncology
25/11/2016 – 26/11/2016, Rome, Italy
Chairs: M.S. Aapro, CH – J. Gligorov, FR
For more detailed info and instructions for registration, consult the ESO website.
Leave a Reply